Skip to main content
SpringerLink
Log in
Book cover

Betablocker — im Mittelpunkt der Forschung pp 74–82Cite as

Koronarer Vasomotorentonus: Einfluß auf die antiischämische Therapie

  • Chapter

  • 33 Accesses

Zusammenfassung

Der koronare Vasomotorentonus spielt in der Pathophysiologic der Angina pectoris eine wichtige Rolle. Eine Erhöhung des Vasomotorentonus während der sympathischen Stimulierung ist beschrieben und mit einer Abnahme des koronaren Blutflusses in Verbindung gebracht worden. Somit kann er eine Myokardischämie auslösen. Bei Patienten mit stabiler Angina pectoris ist nach intrakoronarer Verabreichung von Phentolamin [1, 2] oder Indoramin [3], eines selektiven α1-Rezeptorenblockers, über eine Verminderung der ST-Senkung mit einer Erhöhung der körperlichen Leistungsfähigkeit Berichtet worden.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Beckenboom GM, Abramowitz M, Vandermoten P (1986) S.G. D. Role of a-adrenergic coronary tone in exercise induced angina pectoris. Am J Cardiol 57: 195–198.

    Article  Google Scholar 

  2. Gould L, Reddy GV, Gombrecht RF (1973) Oral phentolamine in angina pectoris. Jpn Heart J 14: 393–397.

    Article  PubMed  CAS  Google Scholar 

  3. Collins P, Sheridan D (1985) Improvement in angina pectoris with a-adrenoceptor blockade. Br Heart J 53: 488–492.

    Article  PubMed  CAS  Google Scholar 

  4. Whitsitt LS, Lucchesi BR (1967) Effects of propanolol and its stereoisomers upon coronary vascular resistance. Circ Res 21: 305–317.

    PubMed  CAS  Google Scholar 

  5. Stephens J, Hayward R, Ead H, Adams L, Hamer J, Spurrell R (1977) Effects of selective and non-selective ß-adrenergic blockade on coronary dynamics in man assessed by rapid atrial pacing. Br Heart J 40: 856–863.

    Article  Google Scholar 

  6. Guth BD, Heusch G, Seitelberger R, Ross JJ (1987) Mechanisms of beneficial effect of ß-adren- ergic blockade on exercise-induced myocardial ischemia in concious dogs. Circ Res 60: 738–746.

    PubMed  CAS  Google Scholar 

  7. Bortone AS, Hess OM, Gaglione A, Suter T, Nonogi H, Grimm J, Krayenbuehl HP (1990) Effect of intravenous propranolol on coronary vasomotion at rest and during dynamic exer¬cise in patients with coronary artery disease. Circulation 81: 1225–1235.

    Article  PubMed  CAS  Google Scholar 

  8. Atterhog J-H, Duner H, Pernow B (1977) Hemodynamic effect of long-term treatment with pindolol in essential hypertension with special reference to the resistance and capacitance vessels of the forearm. Acta Med Scand 202: 517–521.

    Article  PubMed  CAS  Google Scholar 

  9. Brown BG, Lee AB, Bolson EL, Dodge HT (1984) Reflex constriction of significant coronary stenosis as a mechanism contributing to ischemic left ventricular dysfunction during iso- volumetric exercise. Circulation 70: 18–24.

    Article  PubMed  CAS  Google Scholar 

  10. Gage JE, Hess OM, Murakami T, Ritter M, Grimm J, Krayenbuehl HP (1986) Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: Reversibility by nitroglycerin. Circulation 73: 865–876.

    Article  PubMed  CAS  Google Scholar 

  11. Reinwater J, Steele P, Kirch D, LeFree M, Jensen D, Vogel R (1982) Effect of propanolol on myocardial perfusion images and exercise ejection fraction in men with coronary artery disease. Circulation 65: 77–81.

    Article  Google Scholar 

  12. Steele P, Sklar J, Kirch D, Vogel R, Rhodes CA (1983) Thallium-201 myocardial imaging during maximal and submaximal exercise with propanolol. Am Heart J 106: 1353–1357.

    Article  PubMed  CAS  Google Scholar 

  13. Schweizer J, Kaulen R, Altmann E, Nierade A, Nanning T (1996) Sind ß-Blocker bei Patienten mit peripherer arterieller Verschlufikrankheit generell kontraindiziert? Z Kardiol 85: 193–197.

    PubMed  CAS  Google Scholar 

  14. Matsuzaki (1985) Effect of the combination of diltiazem and atenolol on exercise-induced regional myocardial ischemia in conscious dogs. Circulation 72: 233–243.

    Article  PubMed  CAS  Google Scholar 

  15. Yasue H, Omote S, Takizawa A, Nagao M, Miwa K, Tanaka S (1979) Exertional angina pectoris caused by coronary arterial spasm: Effects of various drugs. Am J Cardiol 43: 647–652.

    Article  PubMed  CAS  Google Scholar 

  16. Hodgson J, Cohen MD, Thames MD (1988) ß-blockade results in decreased coronary blood flow due to unopposed a-mediated vasoconstriction. J Am Coll Cardiol 11: 23A.

    Google Scholar 

  17. Wolfson S, Gorlin R (1969) Cardiovascular pharmacology of propanolol in man. Circulation 40: 501–511.

    PubMed  CAS  Google Scholar 

  18. Kern MJ, Ganz P, Horowitz JD et al. (1983) Potentiation of coronary vasoconstriction by ß-adrenergic blockade in patients with coronary artery disease. Circulation 67: 1178–1185.

    Article  PubMed  CAS  Google Scholar 

  19. Heusch G, Deussen A, Thaemer V (1985) Cardiac sympathetic nerve activity and progressive vasoconstriction distal to coronary stenoses: Feed-back aggravation of myocardial ischemia. J Auton Nerv Syst 13: 311–326.

    Article  PubMed  CAS  Google Scholar 

  20. Rajfer SI, Kohli JD, Goldberg LI (1982) Contractile actions of racemic and d-propanolol on isolated canine mesenteric and coronary arteries. J Pharmacol Exp Ther 220: 127–132.

    PubMed  CAS  Google Scholar 

  21. Vatner SF, Hintze TH. Mechanism of constriction of large coronary arteries by ß-adrenergic receptor blockade. Circ Res 53: 389–400.

    Google Scholar 

  22. Rafflenbeul W, Berger C, Jost S, Lichtlen P (1987) Constriction of coronary arteries and stenoses with propanolol. Circulation 76 (suppl IV): IV276.

    Google Scholar 

  23. Heusch G, Deussen A (1983) The effects of cardiac sympathetic nerve stimulation on perfu¬sion of stenotic coronary arteries in the dog. Circ Res 53: 8–15.

    PubMed  CAS  Google Scholar 

  24. Gwirtz PA, Overn SP, Mass HJ, Jones CE (1986) α1-xradrenergic constriction limits coronary flow and cardiac function in running dogs. Am J Physiol 250: H1117–H1126.

    PubMed  CAS  Google Scholar 

  25. Indolfi C, Piscione F, Villari B et al. (1992) Role of α2-adrenoceptors in normal and athero-sclerotic human coronary circulation. Circulation 86: 1116–1124.

    PubMed  CAS  Google Scholar 

  26. Egstrup K, Anderson PE(1993) Transient myocardial ischemia during nifedipine therapy in stable angina pectoris and its relation to coronary collateral flow and comparison with meto-prolol. Am J Cardiol 71: 177–183.

    Article  PubMed  CAS  Google Scholar 

  27. Schulz W, Jost S, Kober G, Kaltenbach M (1985) Relation of antianginal efficacy of nifedipine to degree of coronary arterial narrowing and to presence of coronary collateral vessels. Am J Cardiol 55: 26–32.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. B. Julius
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Kaufmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Vassalli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. O. M. Hess
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institut für Pharmakologie, Med. Universität zu Lübeck, Ratzeburger Allee 160, D-23538, Lübeck, Germany

    P. Dominiak

  2. Division of Cardiology, Sahlgrenska University Hospital, S-413345, Göteborg, Germany

    A. Hjalmarson

  3. Clinical Pharmacology Section, University of Birmingham, Edgbaston, Brimingham B15 2TH, Edgbaston, UK

    M. J. Kendall

  4. Innere Medizin III, Universität Heidelberg, Bergheimer Str. 58, D-69115, Heidelberg, Germany

    W. Kübler

  5. Astra Hässle AB, Clinical R&D, S-43183, Mölndal, Sweden

    G. Olsson

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Julius, B., Kaufmann, P., Vassalli, G., Hess, O.M. (1997). Koronarer Vasomotorentonus: Einfluß auf die antiischämische Therapie. In: Dominiak, P., Hjalmarson, A., Kendall, M.J., Kübler, W., Olsson, G. (eds) Betablocker — im Mittelpunkt der Forschung. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60716-5_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60716-5_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64522-8

  • Online ISBN: 978-3-642-60716-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation